ABOUT US

APIs is what we do

C² PHARMA is a pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds obtained from natural and synthetic origins.

The current API product portfolio includes cyclopentolate, tropicamide, atropine, digoxin, homatropine, pilocarpine, brimonidine, latanoprost, bimatoprost and reaches more than 200 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, Middle-East and Africa.

We are a key sponsor of the “Partnerships for a Better World” program that ensures sustainable, traceable and fair-trade harvesting and sourcing of raw materials for the manufacturing of APIs, such as pilocarpine. The program sustains more than 1,000 families and contributes to the preservation of Brazilian biodiversity.

We are also a member of the United Nations Global Compact: the UN encourages businesses and corporations around the world to adopt sustainable and socially responsible policies and to report on their implementation. We are proud to comply with the four main areas of focus: human rights, labor, environment and anti-corruption.

C² PHARMA also offers customized cold-chain logistics solutions through its specialized affiliate Logistics4Pharma, as well as R&D-scale contract synthesis services, analytical services, phytochemical profiling and impurities manufacturing through its affiliate ASM Research Chemicals.